Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II trial evaluating the long-term efficacy and peripheral sensory neuropathy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer.
Hata T, Uemura M, Danno K, Yoshioka S, Matsuda C, Kagawa Y, Shingai T, Suzuki Y, Tei M, Tanida T, Komori T, Okamura S, Ota H, Takemoto H, Ogino T, Miyoshi N, Yamamoto H, Murata K, Doki Y, Eguchi H. Hata T, et al. Among authors: matsuda c. Sci Rep. 2024 Nov 2;14(1):26434. doi: 10.1038/s41598-024-73222-0. Sci Rep. 2024. PMID: 39488510 Free PMC article. Clinical Trial.
Tolerability and Safety Assessment of Adjuvant Chemoradiotherapy with S-1 after Limited Surgery for T1 or T2 Lower Rectal Cancer.
Miyoshi N, Uemura M, Noura S, Yasui M, Nishimura J, Tei M, Matsuda C, Morita S, Inoue A, Tamagawa H, Mokutani Y, Yoshioka S, Fujii M, Kato S, Sekido Y, Ogino T, Yamamoto H, Murata K, Doki Y, Eguchi H; Multicenter Clinical Study Group of Osaka University, Colorectal Group (CSGO-CG). Miyoshi N, et al. Among authors: matsuda c. Cancers (Basel). 2024 Sep 30;16(19):3360. doi: 10.3390/cancers16193360. Cancers (Basel). 2024. PMID: 39409981 Free PMC article.
Clinical impact of postoperative changes in body composition on long-term outcomes in patients with esophageal cancer.
Takeoka T, Kanemura T, Sugase T, Matsuura N, Sugimura K, Yamamoto M, Shinno N, Hara H, Mukai Y, Hasegawa S, Nishimura J, Akita H, Wada H, Matsuda C, Omori T, Yasui M, Ohue M, Miyata H. Takeoka T, et al. Among authors: matsuda c. Clin Nutr. 2024 Sep;43(9):2188-2194. doi: 10.1016/j.clnu.2024.06.017. Epub 2024 Jun 19. Clin Nutr. 2024. PMID: 39146924
Prognostic Value of a Novel Index Combining the Prognostic Nutritional Index and D-Dimer Levels for Gastric Cancer after Gastrectomy.
Yamamoto M, Omori T, Shinno N, Hara H, Mukai Y, Sugase T, Takeoka T, Kanemura T, Mikamori M, Hasegawa S, Akita H, Haraguchi N, Nishimura J, Wada H, Matsuda C, Yasui M, Miyata H, Ohue M. Yamamoto M, et al. Among authors: matsuda c. Oncology. 2023 Dec 30:1-10. doi: 10.1159/000533150. Online ahead of print. Oncology. 2023. PMID: 38160660
Clinicopathological Characteristics and Survival Outcomes in Patients with Advanced Esophageal Squamous Cell Carcinoma Who Were Intraoperatively Diagnosed Non-Curative.
Sugase T, Kanemura T, Takeoka T, Sugimura K, Yamamoto M, Shinno N, Hara H, Omori T, Mukai Y, Mikamori M, Hasegawa S, Haraguchi N, Akita H, Nishimura J, Wada H, Matsuda C, Yasui M, Miyata H. Sugase T, et al. Among authors: matsuda c. Oncology. 2024;102(5):339-349. doi: 10.1159/000533772. Epub 2023 Nov 3. Oncology. 2024. PMID: 37926097
292 results